Molecular genetics of renal cell carcinoma

Cancer Genetics and Cytogenetics
R Erlandsson

Abstract

Renal cell carcinoma (RCC) is an important clinical problem for which an effective treatment has yet to be developed. Importantly, the 5-year survival is below 50%. A better understanding of the underlying biological mechanisms could result in improvements in the prevention and treatment of this disease. The molecular mapping of chromosomal losses in renal cell cancer together with increased resolution of the human gene map will provide targets for therapeutic approaches. In this review, I summarize what is known regarding some tumor suppressor genes and candidate tumor suppressor genes in RCC, with reference to their location and expression.

References

Sep 13, 1979·The New England Journal of Medicine·A J CohenR S Brown
Oct 28, 1992·Annals of the New York Academy of Sciences·K G LawlorR Narayanan
Oct 1, 1992·Cancer Genetics and Cytogenetics·H J DeckerB R Seizinger
Sep 17, 1992·Nature·S M PowellK W Kinzler
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C F RochlitzR Herrmann
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S LaForgiaA Weston
Sep 1, 1991·Genes, Chromosomes & Cancer·F BoldogG Klein
Dec 1, 1990·Journal of the Neurological Sciences·E R MaherR Harris
Jan 1, 1991·The Journal of Urology·L H KlotzG Mills
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·B R SeizingerJ Whaley
Oct 15, 1990·Cancer Genetics and Cytogenetics·J LimonF Mitelman
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R BooksteinW H Lee
Jun 1, 1989·Cancer Genetics and Cytogenetics·H J DeckerA A Sandberg
Nov 1, 1989·Molecular and Cellular Biology·J M DunnB L Gallie
Nov 1, 1989·Cancer Genetics and Cytogenetics·T A WalterA A Sandberg
Jul 19, 1989·Journal of the National Cancer Institute·K ToryF F Marshall
Jun 1, 1988·Cancer Genetics and Cytogenetics·A H van der HoutC H Buys
Sep 1, 1988·The New England Journal of Medicine·B VogelsteinJ L Bos
Aug 13, 1987·Nature·E SolomonS H Rider
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J P DumanskiM Nordenskjöld
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G KovacsJ Sümegi
Mar 15, 1989·International Journal of Cancer. Journal International Du Cancer·G KovacsW De Riese

❮ Previous
Next ❯

Citations

Jun 17, 1999·International Journal of Cancer. Journal International Du Cancer·T ShishikuraA Nakagawara
Feb 13, 2003·Pathology Oncology Research : POR·Francesca GirolamiFrancesca Torricelli
Apr 15, 2000·Cancer Genetics and Cytogenetics·S GeskB Schlegelberger
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·S J HughesS Hanash
May 31, 2001·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·R DesperA A Schäffer
May 1, 1999·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·R DesperA A Schäffer
Nov 26, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Wen-Chung WangYen-Chein Lai
May 15, 2007·Cancer Genetics and Cytogenetics·Lai-Ching LauSidney Yip
Apr 26, 2005·Clinics in Laboratory Medicine·Timothy D JonesLiang Cheng
Mar 21, 2002·Journal of Pediatric Hematology/oncology·F S HuangB W Warner
May 18, 1999·Current Opinion in Oncology·P A Godley, T E Stinchcombe
May 1, 2002·Current Opinion in Oncology·Paul Godley, Steven W Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.